ES471766A1 - Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza - Google Patents

Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza

Info

Publication number
ES471766A1
ES471766A1 ES471766A ES471766A ES471766A1 ES 471766 A1 ES471766 A1 ES 471766A1 ES 471766 A ES471766 A ES 471766A ES 471766 A ES471766 A ES 471766A ES 471766 A1 ES471766 A1 ES 471766A1
Authority
ES
Spain
Prior art keywords
preparing
dela
influenza
para
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471766A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES471766A1 publication Critical patent/ES471766A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18711Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES471766A 1977-07-22 1978-07-14 Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza Expired ES471766A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81795577A 1977-07-22 1977-07-22

Publications (1)

Publication Number Publication Date
ES471766A1 true ES471766A1 (es) 1979-10-01

Family

ID=25224287

Family Applications (1)

Application Number Title Priority Date Filing Date
ES471766A Expired ES471766A1 (es) 1977-07-22 1978-07-14 Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza

Country Status (9)

Country Link
EP (1) EP0000677B1 (da)
JP (1) JPS5444015A (da)
DE (1) DE2860895D1 (da)
DK (1) DK326878A (da)
EG (1) EG14362A (da)
ES (1) ES471766A1 (da)
IT (1) IT1105533B (da)
PT (1) PT68284A (da)
ZA (1) ZA784161B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
DE3886332T2 (de) * 1987-09-28 1994-03-31 Beecham Inc Inaktivierung von Viren und Bakterien.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5317049B2 (da) * 1972-08-25 1978-06-06

Also Published As

Publication number Publication date
EP0000677B1 (en) 1981-08-05
EG14362A (en) 1984-03-31
DE2860895D1 (en) 1981-11-05
JPS5444015A (en) 1979-04-07
ZA784161B (en) 1980-02-27
IT7850293A0 (it) 1978-07-13
IT1105533B (it) 1985-11-04
DK326878A (da) 1979-01-23
EP0000677A1 (en) 1979-02-07
PT68284A (en) 1978-08-01

Similar Documents

Publication Publication Date Title
Fussell Poultry industry strategies for control of immunosuppressive diseases
ES2152304T3 (es) Procedimiento para el crecimiento del virus del sindrome reproductivo y respiratorio porcino y su uso en vacunas.
DK0610250T3 (da) Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf
DK0650733T3 (da) Levende svækket in ovo-vaccine
SE8005824L (sv) Vaccin av hudparvovirus samt forfarande for dess framstellning
DK401981A (da) Herpes simplex type 1 underenhed vaccine og fremgangsmaade til fremstilling deraf
SE9003198L (sv) Fiskvaccin omfattande en virulent, invasiv bakterie
Heddleston et al. Fowl cholera: immune response in turkeys
GB1593567A (en) Live newcastle disease virus vaccine
JPS5527178A (en) Live influenza virus vaccine
IE780360L (en) Vaccine against "egg drop disease".
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
ES469937A1 (es) Procedimiento para preparar una nueva cepa del virus de la rabia.
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
GB1071922A (en) Improvements in or relating to vaccines
Hofstad Immunity following aerosol exposure to high-embryo-passage avian infectious bronchitis virus
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
US3331736A (en) Modified laryngotracheitis vaccine
ES466758A1 (es) Un procedimiento de preparacion de un virus sincitial respi-ratorio atenuado.
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
GB1481650A (en) Chemical processes and products
ES428370A1 (es) Un procedimiento para preparar una vacuna inmunizante y no patogena para inmunizar aves de corral contra la enfermedad de marek.
Samadieh et al. Demonstration of avian influenza-A virus in Iran by Immunodiffusion technique
Wisniewski et al. Effect of passive immunity of calves, acquired by colostrum, on the results of vaccination against foot-and-mouth disease